Gunnar Wahlberg appointed as acting CEO | IDL Biotech
IDL Biotech

CLOSE MENU

Articles

Latest News

August 2020

Gunnar Wahlberg appointed as acting CEO

The Board has appointed Gunnar Wahlberg as acting CEO.

Read the press release here. 

IDL Biotech förbereder kliniska studier i USA för sitt snabbtest för blåscancer, UBC® Rapid

Under 2019 lämnade IDL Biotech in underlag, en så kallad ”pre-submission request”, till amerikanska FDA (Food and Drug Administration) för att kunna få ett framtida godkännande av UBC® Rapid, bolagets snabbtest för blåscancer. Nu går bolaget vidare och förbereder kliniska studier i USA.

IDL has hired a new production manager

IDL is proud to announce that Jeanpierre Salas Montes will take over as production manager at IDL Biotech. Ola Eklund has decided to retire after more than 20 years at IDL.

IDL Biotech

Skip this intro